As of 2025-07-03, the Relative Valuation of Reneo Pharmaceuticals Inc (RPHM) is (12.38) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.82 USD, the upside of Reneo Pharmaceuticals Inc based on Relative Valuation is -780.5%.
The range of the Relative Valuation is (12.16) - (17.26) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 12.9x - 18.3x | 12.9x |
| Forward P/E multiples | 12.5x - 20.7x | 13.3x |
| Fair Price | (12.16) - (17.26) | (12.38) |
| Upside | -768.0% - -1048.5% | -780.5% |
| Date | P/E |